Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D06AA04	TETRACYCLINE OINTMENT	G	Tetracycline HCl - 3%	3%	Ointment	107,507 L.L
J01AA04	TETRALYSAL	B	Lymecycline - 300mg	300mg	Capsule	796,899 L.L
J05AF07	TENOREAD	G	Tenofovir disoproxil fumarate - 300mg	300mg	Tablet, film coated	7,129,777 L.L
J05AF07	TENVOR	G	Tenofovir disoproxil fumarate - 300mg	300mg	Tablet, film coated	3,753,352 L.L
L04AA23	TYSABRI	BioTech	Natalizumab - 300mg/15ml	300mg/15ml	Injectable concentrated solution	126,830,594 L.L
A10AE04	TOUJEO	BioTech	Insulin glargine - 300Units/ml	300Units/ml	Injectable solution	4,559,658 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	50,113,800 L.L
N02BE01	TYLENOL	B	Paracetamol - 350mg	350mg	Suppository	239,204 L.L
L01FX29	TALVEY	B	Talquetamab - 2mg/ml	3mg/1.5ml	Injectable solution	45,594,403 L.L
S01AE06	TYMER	G	Gatifloxacin (sesquihydrate) - 3mg/ml	3mg/ml	Drops solution	427,342 L.L
J01XA02	TARGOCID	B	Teicoplanin - 400mg	400mg	Injectable lyophilised powder for solution+diluent	1,331,748 L.L
J01XA02	TEICO MEDIS 400	G	Teicoplanin - 400mg	400mg	Injectable lyophilised powder	1,157,048 L.L
S01EE04	TRAVOPROST BIOGARAN	G	Travoprost - 40mcg/ml	40mcg/ml	Drops solution	564,414 L.L
C10AA05	TARDELIP	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,055,876 L.L
C10AA05	TARDEN	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	1,055,876 L.L
C10AA05	TORVACOL 40	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, coated	2,363,819 L.L
C10AA05	TORVALIP 40	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	1,164,664 L.L
C10AA05	TOVAST	G	Atorvastatin (calcium) - 40mg	40mg	Tablet, film coated	2,412,197 L.L
C09CA07	TELMICARD 40	G	Telmisartan - 40mg	40mg	Tablet	659,123 L.L
C09CA07	TOLURA	G	Telmisartan - 40mg	40mg	Tablet	532,162 L.L
C05CX	TANAKAN	B	Ginkgo biloba - 40mg	40mg	Tablet, film coated	661,171 L.L
C05CX	TANAKAN	B	Ginkgo biloba - 40mg	40mg	Tablet, film coated	1,662,333 L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
L01FX29	TALVEY	B	Talquetamab - 40mg/ml	40mg/ml	Injectable solution	555,916,745 L.L
L01FD01	TRASTUREL	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	L.L
L01FD01	TRASTUREL	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	52,047,114 L.L
L01FD01	TRAZIMERA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for solution+solvent	75,295,202 L.L
A04AA01	TRONDAMET	G	Ondansetron (HCl) - 4mg/2ml	4mg/2ml	Injectable solution	2,027,858 L.L
L01CE01	TOPOTU	G	Topotecan HCl - 4mg/4ml	4mg/4ml	Injectable concentrated solution	7,253,796 L.L
N01AF03	THIOPENTAL PANPHARMA	G	Thiopental - 500mg	500mg	Injectable powder for solution	8,446,717 L.L

...